सी.एस.आई.आर - केन्द्रीय औषधि अनुसंधान संस्थान, लखनऊ CSIR-Central Drug Research Institute, Lucknow
This is the new official website for CSIR-CDRI. In case you are facing problem in viewing it properly, please refresh your browser by pressing (Ctrl+Shift+R) to clear your browser cache.
Success Story of Development of New Herbal Medication for Bone Health.
For cerebral malaria as a second line treatment for chloroquine resistant cases, licensed to Themis Chemicals Ltd., Mumbai in 1997.
First non steroidal female oral contraceptive Licensed to HLL Lifecare Ltd., in 1992 & being marketed as SAHELI.
Keenmind is marketed through Soho Flordis International, Sydney, Australia .
Standardized nano-formulation from Spinacea oleracea commonly known as Palak for osteoarthritis.
Identifies the novel action of Witahferin A, a naturally occurring molecule derived from Ashwagandha (Withania somifera, (L.) Dunal) in protecting bones from high fat diet induced changes. Oral administration of the identified molecule was found active, which was also validated in the in vitro system as well.
The study identifies an apicoplast-targeted exonuclease (PfExo) in Plasmodium falciparum with a unique LCR insertion that expands its substrate range and is essential for apicoplast DNA replication. The insertion enhances PfExo's functionality compared to its rodent ortholog, underscoring its critical role in parasite survival.
Oral administration of CSP- TTK21 in mice and rats induces long-term potentiation and improves motor function and regeneration-associated gene expression in spinal injury models, matching the efficacy of intraperitoneal administration without toxicity.
Mantle cell lymphoma is an incurable subtype of B-cell lymphoma which is very heterogeneous. This study identified a few MCL cells adhered to stromal cells have cancer stem cell-like (CSCs) characteristics and expresses high level of lncRNA “CERS-AS1” which regulates oncogenic signaling by stabilizing FGFR1 transcript via mediating its interaction with an RNA binding protein “nucleolin”. Combining nucleolin and FGFR1 targeting agents synergized and induced apoptosis in these lymphoma cells.
Targeting CERS6-AS1/FGFR1 axis as synthetic vulnerability to constrain stromal cells supported proliferation in Mantle cell lymphoma (Leukemia. 2024 Oct;38(10):2196-2209)
Withaferin A Ameliorated the Bone Marrow Fat Content in Obese Male Mice by Favoring Osteogenesis in Bone Marrow Mesenchymal Stem Cells and Preserving the Bone Mineral Density. (ACS Pharmacology & Translational Science 2024 7 (9), 2621-2636)
NMR Spectroscopy
Mass spectrometry
National Laboratory Animal Centre
X-Ray Crystallography
Biological Screening
Common Research and Technology Development Hub (CRTDH)
Bioinformatics & Computational Biology
Toxicity & Safety (GLP certified)
Total Visits: 0